or 24 kg on 15 mg), compared to placebo (2.4%, 5 lb
doi: 10.3389/fphar.2024.1471615 Received 28 July 2024 Accepted 10 October 2024 Published 22 October 2024 Volume 15 - 2024 Edited by Felice Strollo, Endocrinology and Metabolism Unit, IRCCS San Raffaele Pisana, Rome, Italy, Italy Reviewed by Sandro Gentile, University of Campania Luigi Vanvitelli, Italy Maja Cigrovski Berkovic, Clinical Hospital Dubrava, Croatia Updates Copyright 2024 Zhang, Wang and Zhou
Orforglipron, sold under the brand name Foundayo, is a once-daily oral GLP-1 receptor agonist manufactured by Eli Lilly
Int J Mol Med 47:11071156 Lohrasbi P, Karbalay DS, Tabei SMB, Azarpira N, Alaee S, Rafiee B, Bahmanpour S (2022) Melatonin & metformin in PCOS mice